BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen J, Shearer GC, Chen Q, Healy CL, Beyer AJ, Nareddy VB, Gerdes AM, Harris WS, O'Connell TD, Wang D. Omega-3 fatty acids prevent pressure overload-induced cardiac fibrosis through activation of cyclic GMP/protein kinase G signaling in cardiac fibroblasts. Circulation 2011;123:584-93. [PMID: 21282499 DOI: 10.1161/CIRCULATIONAHA.110.971853] [Cited by in Crossref: 109] [Cited by in F6Publishing: 55] [Article Influence: 9.9] [Reference Citation Analysis]
Number Citing Articles
1 Dabkowski ER, O'Connell KA, Xu W, Ribeiro RF Jr, Hecker PA, Shekar KC, Daneault C, Des Rosiers C, Stanley WC. Docosahexaenoic acid supplementation alters key properties of cardiac mitochondria and modestly attenuates development of left ventricular dysfunction in pressure overload-induced heart failure. Cardiovasc Drugs Ther 2013;27:499-510. [PMID: 24013804 DOI: 10.1007/s10557-013-6487-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
2 Heydari B, Abdullah S, Pottala JV, Shah R, Abbasi S, Mandry D, Francis SA, Lumish H, Ghoshhajra BB, Hoffmann U, Appelbaum E, Feng JH, Blankstein R, Steigner M, McConnell JP, Harris W, Antman EM, Jerosch-Herold M, Kwong RY. Effect of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial Infarction: The OMEGA-REMODEL Randomized Clinical Trial. Circulation 2016;134:378-91. [PMID: 27482002 DOI: 10.1161/CIRCULATIONAHA.115.019949] [Cited by in Crossref: 105] [Cited by in F6Publishing: 53] [Article Influence: 17.5] [Reference Citation Analysis]
3 Liu N, Kataoka M, Wang Y, Pu L, Dong X, Fu X, Zhang F, Gao F, Liang T, Pei J, Xiao C, Qiu Q, Hong T, Chen Q, Zhao J, Zhu L, He J, Hu X, Nie Y, Zhu W, Yu H, Cowan DB, Hu X, Wang J, Wang DZ, Chen J. LncRNA LncHrt preserves cardiac metabolic homeostasis and heart function by modulating the LKB1-AMPK signaling pathway. Basic Res Cardiol 2021;116:48. [PMID: 34379189 DOI: 10.1007/s00395-021-00887-3] [Reference Citation Analysis]
4 Bae IS, Kim SH. Expression and Secretion of an Atrial Natriuretic Peptide in Beige-Like 3T3-L1 Adipocytes. Int J Mol Sci 2019;20:E6128. [PMID: 31817347 DOI: 10.3390/ijms20246128] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Polonchuk L, Chabria M, Badi L, Hoflack JC, Figtree G, Davies MJ, Gentile C. Cardiac spheroids as promising in vitro models to study the human heart microenvironment. Sci Rep 2017;7:7005. [PMID: 28765558 DOI: 10.1038/s41598-017-06385-8] [Cited by in Crossref: 86] [Cited by in F6Publishing: 73] [Article Influence: 17.2] [Reference Citation Analysis]
6 Imig JD, Cervenka L, Neckar J. Epoxylipids and soluble epoxide hydrolase in heart diseases. Biochem Pharmacol 2022;195:114866. [PMID: 34863976 DOI: 10.1016/j.bcp.2021.114866] [Reference Citation Analysis]
7 O'Connell TD, Mason RP, Budoff MJ, Navar AM, Shearer GC. Mechanistic insights into cardiovascular protection for omega-3 fatty acids and their bioactive lipid metabolites. Eur Heart J Suppl 2020;22:J3-J20. [PMID: 33061864 DOI: 10.1093/eurheartj/suaa115] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
8 Rainer PP, Kass DA. Old dog, new tricks: novel cardiac targets and stress regulation by protein kinase G. Cardiovasc Res 2016;111:154-62. [PMID: 27297890 DOI: 10.1093/cvr/cvw107] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 5.0] [Reference Citation Analysis]
9 Manson JE, Bassuk SS, Cook NR, Lee IM, Mora S, Albert CM, Buring JE; VITAL Research Group. Vitamin D, Marine n-3 Fatty Acids, and Primary Prevention of Cardiovascular Disease Current Evidence. Circ Res 2020;126:112-28. [PMID: 31895658 DOI: 10.1161/CIRCRESAHA.119.314541] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 8.5] [Reference Citation Analysis]
10 Ito S, Sano Y, Nagasawa K, Matsuura N, Yamada Y, Uchinaka A, Murohara T, Nagata K. Highly purified eicosapentaenoic acid ameliorates cardiac injury and adipose tissue inflammation in a rat model of metabolic syndrome. Obes Sci Pract 2016;2:318-29. [PMID: 27708849 DOI: 10.1002/osp4.50] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
11 Ahmed MA, Abd El Samad AA. Benefits of omega-3 fatty acid against bone changes in salt-loaded rats: possible role of kidney. Physiol Rep 2013;1:e00106. [PMID: 24303178 DOI: 10.1002/phy2.106] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
12 Khan RS, Chokshi A, Drosatos K, Jiang H, Yu S, Harris CR, Schulze PC, Homma S, Blaner WS, Shulman GI, Huang LS, Goldberg IJ. Fish oil selectively improves heart function in a mouse model of lipid-induced cardiomyopathy. J Cardiovasc Pharmacol 2013;61:345-54. [PMID: 23567901 DOI: 10.1097/FJC.0b013e318283d845] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
13 Vu TT, Dieterich P, Vu TT, Deussen A. Docosahexaenoic acid reduces adenosine triphosphate-induced calcium influx via inhibition of store-operated calcium channels and enhances baseline endothelial nitric oxide synthase phosphorylation in human endothelial cells. Korean J Physiol Pharmacol 2019;23:345-56. [PMID: 31496872 DOI: 10.4196/kjpp.2019.23.5.345] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Ma Y, Lindsey ML, Halade GV. DHA derivatives of fish oil as dietary supplements: a nutrition-based drug discovery approach for therapies to prevent metabolic cardiotoxicity. Expert Opin Drug Discov 2012;7:711-21. [PMID: 22724444 DOI: 10.1517/17460441.2012.694862] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
15 Nishizaki Y, Shimada K, Tani S, Ogawa T, Ando J, Takahashi M, Yamamoto M, Shinozaki T, Miyazaki T, Miyauchi K, Nagao K, Hirayama A, Yoshimura M, Komuro I, Nagai R, Daida H. Association between the ratio of serum n-3 to n-6 polyunsaturated fatty acids and acute coronary syndrome in non-obese patients with coronary risk factor: a multicenter cross-sectional study. BMC Cardiovasc Disord 2020;20:160. [PMID: 32252654 DOI: 10.1186/s12872-020-01445-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
16 Yagi S, Fukuda D, Aihara KI, Akaike M, Shimabukuro M, Sata M. n-3 Polyunsaturated Fatty Acids: Promising Nutrients for Preventing Cardiovascular Disease. J Atheroscler Thromb 2017;24:999-1010. [PMID: 28835582 DOI: 10.5551/jat.RV17013] [Cited by in Crossref: 28] [Cited by in F6Publishing: 11] [Article Influence: 5.6] [Reference Citation Analysis]
17 Wu C, Kato TS, Ji R, Zizola C, Brunjes DL, Deng Y, Akashi H, Armstrong HF, Kennel PJ, Thomas T, Forman DE, Hall J, Chokshi A, Bartels MN, Mancini D, Seres D, Schulze PC. Supplementation of l-Alanyl-l-Glutamine and Fish Oil Improves Body Composition and Quality of Life in Patients With Chronic Heart Failure. Circ Heart Fail 2015;8:1077-87. [PMID: 26269566 DOI: 10.1161/CIRCHEARTFAILURE.115.002073] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 2.9] [Reference Citation Analysis]
18 Al-Husseini A, Wijesinghe DS, Farkas L, Kraskauskas D, Drake JI, Van Tassel B, Abbate A, Chalfant CE, Voelkel NF. Increased eicosanoid levels in the Sugen/chronic hypoxia model of severe pulmonary hypertension. PLoS One 2015;10:e0120157. [PMID: 25785937 DOI: 10.1371/journal.pone.0120157] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
19 Haufe S, Utz W, Engeli S, Kast P, Böhnke J, Pofahl M, Traber J, Haas V, Hermsdorf M, Mähler A, Busjahn A, Wiesner S, Otto C, Mehling H, Luft FC, Boschmann M, Schulz-Menger J, Jordan J. Left ventricular mass and function with reduced-fat or reduced-carbohydrate hypocaloric diets in overweight and obese subjects. Hypertension 2012;59:70-5. [PMID: 22068866 DOI: 10.1161/HYPERTENSIONAHA.111.178616] [Cited by in Crossref: 44] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
20 Endo J, Sano M, Isobe Y, Fukuda K, Kang JX, Arai H, Arita M. 18-HEPE, an n-3 fatty acid metabolite released by macrophages, prevents pressure overload-induced maladaptive cardiac remodeling. J Exp Med. 2014;211:1673-1687. [PMID: 25049337 DOI: 10.1084/jem.20132011] [Cited by in Crossref: 96] [Cited by in F6Publishing: 84] [Article Influence: 12.0] [Reference Citation Analysis]
21 Dziubak A, Wójcicka G, Wojtak A, Bełtowski J. Metabolic Effects of Metformin in the Failing Heart. Int J Mol Sci 2018;19:E2869. [PMID: 30248910 DOI: 10.3390/ijms19102869] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 8.0] [Reference Citation Analysis]
22 Semen K, Yelisyeyeva O, Jarocka-Karpowicz I, Kaminskyy D, Solovey L, Skrzydlewska E, Yavorskyi O. Sildenafil reduces signs of oxidative stress in pulmonary arterial hypertension: Evaluation by fatty acid composition, level of hydroxynonenal and heart rate variability. Redox Biol 2016;7:48-57. [PMID: 26654977 DOI: 10.1016/j.redox.2015.11.009] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
23 Galvao TF, Khairallah RJ, Dabkowski ER, Brown BH, Hecker PA, O'Connell KA, O'Shea KM, Sabbah HN, Rastogi S, Daneault C, Des Rosiers C, Stanley WC. Marine n3 polyunsaturated fatty acids enhance resistance to mitochondrial permeability transition in heart failure but do not improve survival. Am J Physiol Heart Circ Physiol 2013;304:H12-21. [PMID: 23103493 DOI: 10.1152/ajpheart.00657.2012] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
24 Gong W, Yan M, Chen J, Chaugai S, Chen C, Wang D. Chronic inhibition of cyclic guanosine monophosphate-specific phosphodiesterase 5 prevented cardiac fibrosis through inhibition of transforming growth factor β-induced Smad signaling. Front Med 2014;8:445-55. [PMID: 25416030 DOI: 10.1007/s11684-014-0378-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
25 Chen K, Kobayashi S, Xu X, Viollet B, Liang Q. AMP activated protein kinase is indispensable for myocardial adaptation to caloric restriction in mice. PLoS One 2013;8:e59682. [PMID: 23527250 DOI: 10.1371/journal.pone.0059682] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
26 Matsuo N, Miyoshi T, Takaishi A, Kishinoue T, Yasuhara K, Tanimoto M, Nakano Y, Onishi N, Ueeda M, Ito H. High Plasma Docosahexaenoic Acid Associated to Better Prognoses of Patients with Acute Decompensated Heart Failure with Preserved Ejection Fraction. Nutrients 2021;13:371. [PMID: 33530352 DOI: 10.3390/nu13020371] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Chen W, Wang Q, Zhou B, Zhang L, Zhu H. Lipid Metabolism Profiles in Rheumatic Diseases. Front Pharmacol 2021;12:643520. [PMID: 33897433 DOI: 10.3389/fphar.2021.643520] [Reference Citation Analysis]
28 Nwosu ZC, Alborzinia H, Wölfl S, Dooley S, Liu Y. Evolving Insights on Metabolism, Autophagy, and Epigenetics in Liver Myofibroblasts. Front Physiol 2016;7:191. [PMID: 27313533 DOI: 10.3389/fphys.2016.00191] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
29 Siddesha JM, Valente AJ, Yoshida T, Sakamuri SS, Delafontaine P, Iba H, Noda M, Chandrasekar B. Docosahexaenoic acid reverses angiotensin II-induced RECK suppression and cardiac fibroblast migration. Cell Signal 2014;26:933-41. [PMID: 24447911 DOI: 10.1016/j.cellsig.2014.01.005] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
30 López B, Ravassa S, Moreno MU, José GS, Beaumont J, González A, Díez J. Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches. Nat Rev Cardiol 2021;18:479-98. [PMID: 33568808 DOI: 10.1038/s41569-020-00504-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
31 Finlin BS, Zhu B, Starnes CP, McGehee RE Jr, Peterson CA, Kern PA. Regulation of thrombospondin-1 expression in alternatively activated macrophages and adipocytes: role of cellular cross talk and omega-3 fatty acids. J Nutr Biochem 2013;24:1571-9. [PMID: 23528972 DOI: 10.1016/j.jnutbio.2013.01.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
32 Garg PK, Guan W, Nomura S, Weir N, Karger AB, Duprez D, Heckbert SR, Tsai MY. Plasma ω-3 and ω-6 PUFA Concentrations and Risk of Atrial Fibrillation: The Multi-Ethnic Study of Atherosclerosis. J Nutr 2021;151:1479-86. [PMID: 33693794 DOI: 10.1093/jn/nxab016] [Reference Citation Analysis]
33 Friedman AN, Yu Z, Tabbey R, Denski C, Tamez H, Wenger J, Thadhani R, Li Y, Watkins BA. Inverse relationship between long-chain n-3 fatty acids and risk of sudden cardiac death in patients starting hemodialysis. Kidney Int 2013;83:1130-5. [PMID: 23389417 DOI: 10.1038/ki.2013.4] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 4.3] [Reference Citation Analysis]
34 Harris WS, Kennedy KF, O'Keefe JH Jr, Spertus JA. Red blood cell fatty acid levels improve GRACE score prediction of 2-yr mortality in patients with myocardial infarction. Int J Cardiol 2013;168:53-9. [PMID: 23044429 DOI: 10.1016/j.ijcard.2012.09.076] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 3.2] [Reference Citation Analysis]
35 Chen G, Xu C, Gillette TG, Huang T, Huang P, Li Q, Li X, Li Q, Ning Y, Tang R, Huang C, Xiong Y, Tian X, Xu J, Xu J, Chang L, Wei C, Jin C, Hill JA, Yang Y. Cardiomyocyte-derived small extracellular vesicles can signal eNOS activation in cardiac microvascular endothelial cells to protect against Ischemia/Reperfusion injury. Theranostics 2020;10:11754-74. [PMID: 33052245 DOI: 10.7150/thno.43163] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
36 Williams EA, Russo V, Ceraso S, Gupta D, Barrett-Jolley R. Anti-arrhythmic properties of non-antiarrhythmic medications. Pharmacol Res 2020;156:104762. [PMID: 32217149 DOI: 10.1016/j.phrs.2020.104762] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
37 Wang JH, Eguchi K, Matsumoto S, Fujiu K, Komuro I, Nagai R, Manabe I. The ω-3 polyunsaturated fatty acid, eicosapentaenoic acid, attenuates abdominal aortic aneurysm development via suppression of tissue remodeling. PLoS One 2014;9:e96286. [PMID: 24798452 DOI: 10.1371/journal.pone.0096286] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
38 Ramadeen A, Dorian P. How Are n-3 LCPUFAs Antiarrhythmic? A Reassessment of n-3 LCPUFAs in Cardiac Disease. Cardiol Res Pract 2012;2012:746709. [PMID: 22953156 DOI: 10.1155/2012/746709] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
39 van Borren MM, den Ruijter HM, Baartscheer A, Ravesloot JH, Coronel R, Verkerk AO. Dietary Omega-3 Polyunsaturated Fatty Acids Suppress NHE-1 Upregulation in a Rabbit Model of Volume- and Pressure-Overload. Front Physiol 2012;3:76. [PMID: 22485092 DOI: 10.3389/fphys.2012.00076] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
40 Upadhya B, Haykowsky MJ, Kitzman DW. Therapy for heart failure with preserved ejection fraction: current status, unique challenges, and future directions. Heart Fail Rev 2018;23:609-29. [PMID: 29876843 DOI: 10.1007/s10741-018-9714-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
41 Chen YT, Wong LL, Liew OW, Richards AM. Heart Failure with Reduced Ejection Fraction (HFrEF) and Preserved Ejection Fraction (HFpEF): The Diagnostic Value of Circulating MicroRNAs. Cells 2019;8:E1651. [PMID: 31888288 DOI: 10.3390/cells8121651] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
42 Afanas'ev I. ROS and RNS signaling in heart disorders: could antioxidant treatment be successful? Oxid Med Cell Longev 2011;2011:293769. [PMID: 21912722 DOI: 10.1155/2011/293769] [Cited by in Crossref: 47] [Cited by in F6Publishing: 54] [Article Influence: 4.3] [Reference Citation Analysis]
43 Hiki M, Miyazaki T, Shimada K, Sugita Y, Shimizu M, Aikawa T, Ouchi S, Shiozawa T, Takasu K, Takahashi S, Takagi A, Miyauchi K, Daida H. Significance of Serum Polyunsaturated Fatty Acid Level Imbalance in Patients with Acute Venous Thromboembolism. J Atheroscler Thromb 2017;24:1016-22. [PMID: 28344195 DOI: 10.5551/jat.37424] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
44 Wang C, Kemp-Harper BK, Kocan M, Ang SY, Hewitson TD, Samuel CS. The Anti-fibrotic Actions of Relaxin Are Mediated Through a NO-sGC-cGMP-Dependent Pathway in Renal Myofibroblasts In Vitro and Enhanced by the NO Donor, Diethylamine NONOate. Front Pharmacol 2016;7:91. [PMID: 27065874 DOI: 10.3389/fphar.2016.00091] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
45 Eclov JA, Qian Q, Redetzke R, Chen Q, Wu SC, Healy CL, Ortmeier SB, Harmon E, Shearer GC, O'Connell TD. EPA, not DHA, prevents fibrosis in pressure overload-induced heart failure: potential role of free fatty acid receptor 4. J Lipid Res 2015;56:2297-308. [PMID: 26435012 DOI: 10.1194/jlr.M062034] [Cited by in Crossref: 26] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
46 Zhang F, Fu X, Kataoka M, Liu N, Wang Y, Gao F, Liang T, Dong X, Pei J, Hu X, Zhu W, Yu H, Cowan DB, Hu X, Huang ZP, Wang J, Wang DZ, Chen J. Long noncoding RNA Cfast regulates cardiac fibrosis. Mol Ther Nucleic Acids 2021;23:377-92. [PMID: 33473324 DOI: 10.1016/j.omtn.2020.11.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
47 Limbu R, Cottrell GS, McNeish AJ. Characterisation of the vasodilation effects of DHA and EPA, n-3 PUFAs (fish oils), in rat aorta and mesenteric resistance arteries. PLoS One. 2018;13:e0192484. [PMID: 29394279 DOI: 10.1371/journal.pone.0192484] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
48 O'Connell TD, Block RC, Huang SP, Shearer GC. ω3-Polyunsaturated fatty acids for heart failure: Effects of dose on efficacy and novel signaling through free fatty acid receptor 4. J Mol Cell Cardiol 2017;103:74-92. [PMID: 27986444 DOI: 10.1016/j.yjmcc.2016.12.003] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 5.5] [Reference Citation Analysis]
49 Wu JH, Lemaitre RN, King IB, Song X, Sacks FM, Rimm EB, Heckbert SR, Siscovick DS, Mozaffarian D. Association of plasma phospholipid long-chain ω-3 fatty acids with incident atrial fibrillation in older adults: the cardiovascular health study. Circulation. 2012;125:1084-1093. [PMID: 22282329 DOI: 10.1161/circulationaha.111.062653] [Cited by in Crossref: 104] [Cited by in F6Publishing: 62] [Article Influence: 10.4] [Reference Citation Analysis]
50 Stanley WC, Dabkowski ER, Ribeiro RF Jr, O'Connell KA. Dietary fat and heart failure: moving from lipotoxicity to lipoprotection. Circ Res 2012;110:764-76. [PMID: 22383711 DOI: 10.1161/CIRCRESAHA.111.253104] [Cited by in Crossref: 81] [Cited by in F6Publishing: 41] [Article Influence: 8.1] [Reference Citation Analysis]
51 Stanley WC, Cox JW, Asemu G, O'Connell KA, Dabkowski ER, Xu W, Ribeiro RF Jr, Shekar KC, Hoag SW, Rastogi S, Sabbah HN, Daneault C, des Rosiers C. Evaluation of docosahexaenoic acid in a dog model of hypertension induced left ventricular hypertrophy. J Cardiovasc Transl Res 2013;6:1000-10. [PMID: 24065618 DOI: 10.1007/s12265-013-9511-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
52 Yagi S, Hara T, Ueno R, Aihara K, Fukuda D, Takashima A, Hotchi J, Ise T, Yamaguchi K, Tobiume T, Iwase T, Yamada H, Soeki T, Wakatsuki T, Shimabukuro M, Akaike M, Sata M. Serum concentration of eicosapentaenoic acid is associated with cognitive function in patients with coronary artery disease. Nutr J 2014;13:112. [PMID: 25471307 DOI: 10.1186/1475-2891-13-112] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
53 He Z, Yang Y, Wen Z, Chen C, Xu X, Zhu Y, Wang Y, Wang DW. CYP2J2 metabolites, epoxyeicosatrienoic acids, attenuate Ang II-induced cardiac fibrotic response by targeting Gα12/13. J Lipid Res 2017;58:1338-53. [PMID: 28554983 DOI: 10.1194/jlr.M074229] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
54 Meng H, Zhao Y, Dong J, Xue M, Lin YS, Ji Z, Mai WX, Zhang H, Chang CH, Brinker CJ, Zink JI, Nel AE. Two-wave nanotherapy to target the stroma and optimize gemcitabine delivery to a human pancreatic cancer model in mice. ACS Nano 2013;7:10048-65. [PMID: 24143858 DOI: 10.1021/nn404083m] [Cited by in Crossref: 110] [Cited by in F6Publishing: 103] [Article Influence: 12.2] [Reference Citation Analysis]
55 Laake K, Seljeflot I, Schmidt EB, Myhre P, Tveit A, Norseth J, Arnesen H, Solheim S. Galectin-3, a marker of cardiac remodeling, is inversely related to serum levels of marine omega-3 fatty acids. A cross-sectional study. JRSM Cardiovasc Dis 2017;6:2048004017729984. [PMID: 28932392 DOI: 10.1177/2048004017729984] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
56 Kalish BT, Matte A, Andolfo I, Iolascon A, Weinberg O, Ghigo A, Cimino J, Siciliano A, Hirsch E, Federti E, Puder M, Brugnara C, De Franceschi L. Dietary ω-3 fatty acids protect against vasculopathy in a transgenic mouse model of sickle cell disease. Haematologica 2015;100:870-80. [PMID: 25934765 DOI: 10.3324/haematol.2015.124586] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 5.1] [Reference Citation Analysis]